Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tailong Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 7
Lead investments 1
Key employees Soon

Areas of investment

  • Medical
  • Biotechnology
  • Medical Device
  • Pharmaceutical
  • Biopharma

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

XellSmart

Biopharma
Biotechnology
Pharmaceutical
21 Oct 2024 Minhang, Shanghai, China

BiyoPharma

26 Apr 2024 -

St Phi Therapeutics

$15M15 Apr 2024 Shanghai, Shanghai, China

LeadBio Tech

Biotechnology
Medical
Medical Device
$15M13 Nov 2023 Hangzhou, Zhejiang, China

Cytocares

Biotechnology
Medical
Product Research
$15M17 May 2023 -

Lab Direct

Medical
Medical Device
$10M26 Aug 2022 Shanghai, Shanghai, China

Haixin zhihui

Artificial Intelligence
Health Care
Medical
Medical Device
25 May 2022 Hangzhou, Zhejiang, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tailong Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 8M
Peak activity year 2024
Lead investments 1
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

XellSmart

Biopharma
Biotechnology
Pharmaceutical
21 Oct 2024 Minhang, Shanghai, China

BiyoPharma

26 Apr 2024 -

St Phi Therapeutics

$15M15 Apr 2024 Shanghai, Shanghai, China

LeadBio Tech

Biotechnology
Medical
Medical Device
$15M13 Nov 2023 Hangzhou, Zhejiang, China

Cytocares

Biotechnology
Medical
Product Research
$15M17 May 2023 -

Lab Direct

Medical
Medical Device
$10M26 Aug 2022 Shanghai, Shanghai, China

Haixin zhihui

Artificial Intelligence
Health Care
Medical
Medical Device
25 May 2022 Hangzhou, Zhejiang, China
Crunchbase icon

Content report

The following text will be sent to our editors: